Riferimenti Bibliografici American Society of Clinical Oncology. (2015). The state of cancer care in America, 2015: a report by the American Society of Clinical Oncology. Journal of oncology practice, 11(2), 79-113. Bittner, B., Richter, W., & Schmidt, J. (2018). Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities. BioDrugs, 32(5), 425-440. Buzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., ... & Cristofanilli, M. (2005). Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. Journal of clinical oncology, 23(16), 36763685. Chevreul, K., Com-Ruelle, L., Midy, F., & Paris, V. (2004). Le développement des services de soins hospitaliers à domicile: éclairage des expériences australienne, britannique et canadienne. Questions d'économie de la santé, (91), 1-8. Chini, C., Bascialla, L., Giaquinto, A., Magni, E., Gobba, S. M., Proserpio, I., ... & Pinotti, G. (2020). Homcology: Home chemotherapy delivery in a simultaneous care project for frail advanced cancer patients. Supportive Care in Cancer, 1-7. Cicchetti A, Coretti S, Di Brino E, Mascia D, Refolo P, Rolli FR, Rumi F, Sacchini D, Sacco F, Spagnolo AG. Mini HTA di rituximab e trastuzumab in formulazione sottocutanea, Working Paper Altems n. 1, 2017. Cool, L., Vandijck, D., Debruyne, P., Desmedt, M., Lefebvre, T., Lycke, M., ... & Van Eygen, K. (2018). Organization, quality and cost of oncological home-hospitalization: A systematic review. Critical Reviews in Oncology/Hematology, 126, 145-153. Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, Michielin O, Peters S, Tabernero J, Douillard JY, Pentheroudakis G; Panel members. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020 Oct;31(10):1320-1335. Denys, H., Martinez-Mena, C. L., Martens, M. T., D’Hondt, R. G., Graas, M. P. L., Evron, E., ... & Van Steenberghe, M. M. (2020). Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer. Breast cancer research and treatment, 181(1), 97. Farfan-Portet, M., Alain, D., Lut, M., Francois, D., Mistiaen, P., & Gerkens, S. (2015). Implementation of hospital at home: orientations for Belgium. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). George J, Shalansky SJ (2007) Predictors of refill non-adherence inpatients with heart failure. Br J Clin Pharmacol 63:488–493
44
